NZ212390A - Slow release pharmacological formulation with crystalline matrix as carrier - Google Patents

Slow release pharmacological formulation with crystalline matrix as carrier

Info

Publication number
NZ212390A
NZ212390A NZ212390A NZ21239085A NZ212390A NZ 212390 A NZ212390 A NZ 212390A NZ 212390 A NZ212390 A NZ 212390A NZ 21239085 A NZ21239085 A NZ 21239085A NZ 212390 A NZ212390 A NZ 212390A
Authority
NZ
New Zealand
Prior art keywords
active agent
dispersion
pharmaceutical composition
matrix
dispersion according
Prior art date
Application number
NZ212390A
Other languages
English (en)
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority to NZ22905985A priority Critical patent/NZ229059A/xx
Priority to NZ23395485A priority patent/NZ233954A/en
Publication of NZ212390A publication Critical patent/NZ212390A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ212390A 1984-06-14 1985-06-12 Slow release pharmacological formulation with crystalline matrix as carrier NZ212390A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ22905985A NZ229059A (en) 1984-06-14 1985-06-12 Pharmaceutical compositions containing 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-ethoxycarbonyl-2,6-dimethyl-3-pyridine carboxylic acid ethyl ester
NZ23395485A NZ233954A (en) 1984-06-14 1985-06-12 Sustained release pharmaceutical composition comprising 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridine carboxylic acid isopropyl ester

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (1)

Publication Number Publication Date
NZ212390A true NZ212390A (en) 1992-02-25

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ212390A NZ212390A (en) 1984-06-14 1985-06-12 Slow release pharmacological formulation with crystalline matrix as carrier

Country Status (21)

Country Link
AT (1) AT391806B (fr)
AU (2) AU587190B2 (fr)
BE (1) BE902626A (fr)
CA (1) CA1264441A (fr)
CY (1) CY1635A (fr)
DE (1) DE3520184C2 (fr)
DK (1) DK167649B1 (fr)
ES (1) ES8702141A1 (fr)
FR (1) FR2565822B1 (fr)
GB (3) GB2160100B (fr)
GR (1) GR851430B (fr)
HK (1) HK25192A (fr)
HU (1) HU198844B (fr)
IE (1) IE58834B1 (fr)
IL (1) IL75490A0 (fr)
IT (1) IT1200080B (fr)
LU (1) LU85946A1 (fr)
NL (1) NL194389C (fr)
NZ (1) NZ212390A (fr)
PT (1) PT80635B (fr)
SE (1) SE504583C2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
CA2231195C (fr) * 1996-07-08 2003-01-21 Edward Mendell Co., Inc. Matrice a liberation prolongee pour medicaments insolubles en doses elevees
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
AU5483600A (en) * 1999-06-11 2001-01-02 Jean A. Chmielewski Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
WO2001010466A1 (fr) * 1999-08-04 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicinales stables pour administration orale
CA2352211C (fr) 1999-09-30 2009-03-24 Edward Mendell Co., Inc. Systemes de matrice a liberation prolongee pour medicaments hautement solubles
CA2434835A1 (fr) * 2001-02-13 2002-08-22 Astrazeneca Ab Nouvelle formulation a liberation modifiee
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (fr) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Procedé pour la préparation des formes de dosage comprenant une dispersion solide d'un agent active microcristalline
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
JP2010511713A (ja) 2006-12-05 2010-04-15 ランデック コーポレイション 薬物送達
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
JP2012501967A (ja) * 2008-08-20 2012-01-26 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 調節放出型多粒子のホットメルト押出成形

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
EP0001247A1 (fr) * 1977-09-14 1979-04-04 Kanebo, Ltd. Composition pharmaceutique contenant de la nifédipine et procédé pour sa préparation.
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (fr) * 1981-10-29 1993-02-10 Bayer Ag Procédé de fabrication de préparations pharmaceutiques solides à libération rapide de dihydropyridines
CA1208558A (fr) * 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
AU4348685A (en) 1985-12-19
GB2196851B (en) 1989-06-07
DE3520184C2 (de) 1997-03-13
GB2160100B (en) 1989-06-01
SE504583C2 (sv) 1997-03-10
IT8548210A0 (it) 1985-06-13
GB2196851A (en) 1988-05-11
ES544075A0 (es) 1987-01-01
FR2565822A1 (fr) 1985-12-20
FR2565822B1 (fr) 1989-02-17
GB8727056D0 (en) 1987-12-23
CY1635A (en) 1992-11-06
HUT40918A (en) 1987-03-30
HU198844B (en) 1989-12-28
HK25192A (en) 1992-04-10
IE58834B1 (en) 1993-11-17
IT1200080B (it) 1989-01-05
ATA174885A (de) 1990-06-15
GB2196852A (en) 1988-05-11
SE8502950L (sv) 1985-12-15
BE902626A (fr) 1985-12-10
NL8501578A (nl) 1986-01-02
AU587190B2 (en) 1989-08-10
GR851430B (fr) 1985-11-25
PT80635B (pt) 1987-10-20
DK264785A (da) 1985-12-15
GB8727055D0 (en) 1987-12-23
CA1264441A (fr) 1990-01-16
DK167649B1 (da) 1993-12-06
GB8514855D0 (en) 1985-07-17
SE8502950D0 (sv) 1985-06-13
AU4454389A (en) 1990-03-22
IL75490A0 (en) 1985-10-31
LU85946A1 (fr) 1986-01-24
GB2160100A (en) 1985-12-18
DE3520184A1 (de) 1985-12-19
ES8702141A1 (es) 1987-01-01
PT80635A (en) 1985-07-01
DK264785D0 (da) 1985-06-12
GB2196852B (en) 1989-05-17
AT391806B (de) 1990-12-10
IE851460L (en) 1985-12-14
NL194389B (nl) 2001-11-01
NL194389C (nl) 2002-03-04

Similar Documents

Publication Publication Date Title
NZ212390A (en) Slow release pharmacological formulation with crystalline matrix as carrier
CA1304294C (fr) Preparations pharmaceutiques a liberation prolongee
EP0097523B1 (fr) Compositions à libération contrôlée et prolongée
FI92903B (fi) Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä
EP2538925B1 (fr) Formulations d'apixaban
EP2180883B1 (fr) Composition pharmaceutique contenant un antagoniste des canaux calciques de type dihydropyridine et son procédé de préparation
PL206595B1 (pl) Preparat farmaceutyczny w postaci mikrosfer, sposób wytwarzania tego preparatu oraz farmaceutyczna postać dawkowania zawierająca ten preparat
KR20000005554A (ko) 방출 지속성 다분산 하이드로겔 시스템 - 비정질 약물
WO2006085208A2 (fr) Formes galeniques solides stables d'amlodipine et de benazepril
JP3110794B2 (ja) １，４−ジヒドロピリジン誘導体を含有する製剤
WO2005115346A2 (fr) Composition contenant de la risperidone
CA3228055A1 (fr) Comprime a liberation controlee par pompe osmotique d'un medicament insoluble et son procede de preparation
NZ233954A (en) Sustained release pharmaceutical composition comprising 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridine carboxylic acid isopropyl ester
KR890001501B1 (ko) 조절된 서방성을 지닌 활성제의 고형분산액 제조방벙
JPS6110507A (ja) 新規遅効性製剤
CH670201A5 (en) Solid dispersions of water-insol. drugs - comprising coherent crystals of drug in water-soluble matrix
MXPA00006574A (en) Method and composition of an oral preparation of itraconazole
SI8710407A (sl) Postopek za pridobivanje trdnega pripravka s podaljšanim sproščanjem aktivne spojine